4 Nov 2021
Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones
Author: admintech | Filed under: Press ReleaseCAMBRIDGE, Mass., Nov. 4, 2021 /PRNewswire/ — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today reported financial results for the third quarter ended September 30, 2021 and highlighted…